Howdy, it may be silly, but it's true, no one can sell a share unless someone else (maybe stupid like me) buys it.
The LAST thing we want is a buyout when you're down 90% since merger.
What we DO want is a collaboration deal with a big pharma for AML and then kick the rest of the pipeline in to high gear.
I think the big bucks could come from Pancreatic in the future.
I have been investing in biotech for decades. I watch and see what has happened to MRKR share price over the last few years.
I have seen the EXACT same thing with several others that I owned.
Look at charts of (before they took off) of ARWR, ALNY, MRTX, EXEL, SGEN, AVXL and others.